Integrity Applications appoints Luis Malavé to its Board of Directors

– ISRAEL, Ashdod –  Integrity Applications, Inc. (OTC: IGAP), innovator of GlucoTrack, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, today announced the appointment of Luis Malavé to its Board of Directors, effective immediately.

“Luis’s impressive track record of working with medical device companies from product development to market expansion and high growth is ideally suited to Integrity,” said Board member, Dr. Paul Goode. “His expertise in the consumer diabetes space reflects our focus on developing Integrity into a dominant player in the diabetes management industry.”

About Luis Malavé

Mr. Malavé brings more than 30 years of leadership experience in the MedTech industry, primarily in diabetes management, spanning all company stages, from private startups to large-cap publicly listed companies. He has extensive expertise in product development, operations, marketing, strategic partnerships, and US FDA regulatory strategy.

Mr. Malavé currently serves as President of EOFLOW CO. Ltd., a company listed on the Korea Stock Exchange that has developed a wearable disposable insulin pump. Before that, Mr. Malavé was the President and CEO of Palyon Medical, maker of an implantable drug-delivery system that spun out from German medical-technology giant Fresenius SE. Prior to Palyon, he spent nearly a decade at insulin pump maker Insulet Corp., including as its SVP of Research, Development and Engineering, and as COO. He also held various senior positions at Medtronic and MiniMed, overseeing the product development of various diabetes management devices.

“I’ve spent most of my career focused on innovations in diabetes patient care and I have witnessed firsthand the positive impact medical technology can have on people’s lives,” said Mr. Malavé. “I look forward to working alongside my fellow board members and company management to advance this truly innovative technology that has the potential to help millions of people suffering from diabetes and prediabetes around the world.”

Mr. Malavé earned his Bachelor’s degree in Mathematics and Computer Science from the University of Minnesota, a Master’s degree in Software Engineering from the University of St. Thomas, and an MBA from the University of Maryland.

About Integrity Applications, Inc.

Integrity Applications, Inc. was founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. The Company has developed GlucoTrack, a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements in about a minute without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices. Integrity Applications Inc. is a Delaware corporation, with headquarters in the United States and an R&D site in Ashdod, Israel.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team